Science News

Health Medical

Adalvo expands biosimilars portfolio through acquisition of romiplostim biosimilar program from Enzene

By News Medical #acquisition, #Adalvo, #Biosimilar, #Biosimilars, #Enzene, #expands, #Health, #Medical, #medicine, #portfolio, #Program, #romiplostim


Adalvo today announced the acquisition of a romiplostim biosimilar program referencing Nplate® from Enzene, strengthening its biosimilars portfolio and accelerating the company’s expansion into complex biological medicines.

By News Medical

Related Post

Health Psychology

Men and women report similar levels of “duty sex,” and similar reasons behind it

PsyPost
Health Medical

Alcami announces promotion of Robert Tragas to Vice President, Laboratory Services

News Medical
Health Psychology

Horror isn’t just intense fear, new psychology study suggests

PsyPost

You Missed

Health Medical

Adalvo expands biosimilars portfolio through acquisition of romiplostim biosimilar program from Enzene

Health Psychology

Men and women report similar levels of “duty sex,” and similar reasons behind it

Core Science Latest Physics

Maxwell's Demon Can Extract Energy From Hidden Memories, Study Finds

Latest

Sci-fi horror collides with small-town politics in John Scalzi’s Monsters of Ohio